Figure 2.
Progression-free survival with optimal and real-world adherence (A) and in adherent and nonadherent patients (B) treated with axitinib and everolimus.
Abbreviation: MPR, medication possession ratio.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.